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Development of sustained release gastroretentive floating tablets using HME coupled 3D printing: A QbD approach
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The main objective of this study was to develop sustained
release gastroretentive floating tablets using fused filament
fabrication (FFF) 3D printing and evaluate the effect of
formulation and process variables on in vitro drug release
characteristics using Quality by Design (QbD) approach.
Hot Melt Extrusion: Hydroxypropyl methylcellulose (HPMC
E5), ethyl cellulose (EC-N14), and acetaminophen (APAP)
(model drug) were blended using maxiblend™
(globepharma, new brunswick, NJ, USA) at 25 rpm for 15
minutes. A 11mm twin screw extruder (thermo fisher
scientific, waltham, MA, USA) was used to extrude
cylindrical filaments with a 1.75mm diameter to be used as
feedstock material for 3D printing.
3D Printing: The tablets were designed as hollow cylindrical
objects (d=12.4mm, h=5mm) to decrease density and float
in gastric medium, using tinkercad™ free online software
(autodesk, CA, USA). Combining both these digital files and
previously extruded filaments, the gastroretentive floating
tablets were prepared using a FFF based 3D printer (prusa
i3 3D desktop printer, prusa research, prague, czech
republic). The formulation variables (% drug load, EC
concentration) and process variables (shell thickness) were
chosen as independent variables and % drug release at 2h,
6h and 10h were chosen as dependent variables (Table 1,
2 & 3.). A response surface method with three-factor, three-
level box–behnken design was applied for the optimization
of sustained release floating tablets.
Characterization: Thermal stability of polymers in the study
was assessed using thermogravimetric analysis (TGA) and
differential scanning calorimetry (DSC). Mechanical
properties of the extruded filaments were determined using
a texture analyzer (TA-XT2i analyzer, texture technologies,
MA, USA). (Figure 1.). The printed tablets were evaluated
for in vitro drug release and floating ability in 0.1N HCl
dissolution media. (Figure 2.).
Table 1. DoE independent and dependent variables Table 2. Runs suggested by the DoE software 
Figure 1. Stiffness values of all the extruded filaments 
analyzed by Repka-zhang test
Figure 2. In vitro drug release profile of sustained release floating 
tablets in 0.1N HCl
Table 3. Cumulative drug release values of all the 
formulations at 2h, 6h and 10thh
Table 4. Model summaries of the QbD experiments 
✓ The coefficients of % APAP are positive implying that drug dissolution increases with increase in
API load.
✓ Whereas the coefficients of both shell thickness and % EC are negative indicating drug
dissolution decreases with increase in shell thickness or % EC.
✓ % EC had greatest effect on drug release profiles whereas shell thickness had the least effect.
✓ Both % APAP and % EC significantly influenced the drug release at 2h, 6h and 10h (p<0.05),
where as shell thickness had significant effect at only at 2h and 6h and lost effect at 10 h
(p=0.0636).(Table 4.)
✓ No interaction is seen between all three factors (p>0.05), but at 10th h, when shell thickness lost
effect, there is an interaction between drug load and % EC (p=0.0053). (Table 4.).
✓ APAP, is freely water-soluble drug, so as the % APAP increased in formulation , the drug release
increased.
✓ EC is a hydrophobic and water insoluble polymer, so as % EC is increased, drug release
decreased
✓ Shell has separate fill pattern and denser structure compared to core of tablet. So higher shell
thickness successfully prevented the entry of dissolution media for longer time and resulted in
reduced drug release.
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✓ Filaments suitable for FFF 3D printing were
successfully fabricated using different ratios HPMC,
EC and APAP.
✓ All the three independent factors studied had
significant effect on drug release profiles.
✓ QbD was applied to assess the effect of formulation and
process parameters on in vitro drug release
characteristics.
✓ Sustained release gastroretentive floating tablets were
prepared with HME coupled 3D printing.
✓ All the printed tablets exhibited good floating behavior
throughout the dissolution studies.
✓ FFF 3D printing combined with QbD is a novel viable tool
for fabricating customized dosage forms for personalized
pharmacotherapy.
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